Literature DB >> 10656696

Transcriptional repression of the human p53 gene by hepatitis B viral X protein.

S G Lee1, H M Rho.   

Abstract

Hepatitis B viral X protein (HBx) and the human p53 protein (p53) have been known as a transactivator and as a tumor suppressor, respectively. These two proteins have also been known to interact with each other to neutralize their authentic functions and the p53 represses the HBV enhancer/X promoter activity. Here we report that the promoter activity of the human p53 gene was strongly repressed by the HBx using the chloramphenicol acetyl transferase (CAT) assay. Analyses of serial deletion, site-directed mutagenesis and the heterologous promoter system showed that the site responsible for the repression was the E-box element in the promoter of the p53 gene. In addition, HBx as expected also repressed the activation of the p53 promoter by c-Myc through the E-box element. Northern blot analyses also showed that the expression of the p53 gene in the HepG2-K8 cell line, which expresses HBV genes including HBx, was much more repressed than that of the control cell HepG2. These results with previous data suggest that the shift of the reciprocal inhibitory activities at the levels of protein-protein interaction and transcription between HBx and p53 may play a decisive role in the HBV-related hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656696     DOI: 10.1038/sj.onc.1203312

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

Review 1.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  Genetics of hepatocellular carcinoma.

Authors:  Andreas Teufel; Frank Staib; Stephan Kanzler; Arndt Weinmann; Henning Schulze-Bergkamen; Peter-R Galle
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

Review 3.  Viral manipulation of DNA repair and cell cycle checkpoints.

Authors:  Mira S Chaurushiya; Matthew D Weitzman
Journal:  DNA Repair (Amst)       Date:  2009-05-26

Review 4.  Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Authors:  Renumathy Dhanasekaran; Jean-Charles Nault; Lewis R Roberts; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2018-11-04       Impact factor: 22.682

Review 5.  Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.

Authors:  Amir Shlomai; Ype P de Jong; Charles M Rice
Journal:  Semin Cancer Biol       Date:  2014-01-20       Impact factor: 15.707

6.  A mutant of hepatitis B virus X protein (HBx Delta 127) enhances hepatoma cell migration via osteopontin involving 5-lipoxygenase.

Authors:  Xuan Zhang; Li-hong Ye; Xiao-dong Zhang
Journal:  Acta Pharmacol Sin       Date:  2010-04-05       Impact factor: 6.150

Review 7.  Hepatitis viruses exploitation of host DNA methyltransferases functions.

Authors:  Valerio Pazienza; Concetta Panebianco; Angelo Andriulli
Journal:  Clin Exp Med       Date:  2015-07-07       Impact factor: 3.984

8.  Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue.

Authors:  Cory L Grand; Tiffanie J Powell; Raymond B Nagle; David J Bearss; Denise Tye; Mary Gleason-Guzman; Laurence H Hurley
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-12       Impact factor: 11.205

Review 9.  Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis.

Authors:  Yasunobu Matsuda; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

10.  High-level expression and large-scale preparation of soluble HBx antigen from Escherichia coli.

Authors:  Dong Liu; Liyun Zou; Wanling Li; Li Wang; Yuzhang Wu
Journal:  Biotechnol Appl Biochem       Date:  2009-09-24       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.